Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1962 2
1963 4
1964 3
1965 2
1966 2
1968 2
1970 2
1971 2
1974 1
1975 1
1976 5
1979 1
1980 1
1982 2
1983 1
1984 2
1985 6
1986 2
1987 6
1988 10
1989 11
1990 8
1991 3
1992 3
1993 4
1994 4
1995 4
1996 3
1997 5
1998 6
1999 8
2000 10
2001 15
2002 14
2003 2
2004 3
2005 9
2006 12
2007 14
2008 6
2009 13
2010 20
2011 22
2012 17
2013 16
2014 24
2015 26
2016 33
2017 45
2018 44
2019 44
2020 60
2021 51
2022 45
2023 42

Text availability

Article attribute

Article type

Publication date

Search Results

614 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
Räber L, Ueki Y, Otsuka T, Losdat S, Häner JD, Lonborg J, Fahrni G, Iglesias JF, van Geuns RJ, Ondracek AS, Radu Juul Jensen MD, Zanchin C, Stortecky S, Spirk D, Siontis GCM, Saleh L, Matter CM, Daemen J, Mach F, Heg D, Windecker S, Engstrøm T, Lang IM, Koskinas KC; PACMAN-AMI collaborators. Räber L, et al. Among authors: ueki y. JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218. JAMA. 2022. PMID: 35368058 Free PMC article. Clinical Trial.
Bioresorbable Scaffolds: Unfulfilled Prophecies.
Räber L, Ueki Y. Räber L, et al. Among authors: ueki y. Circulation. 2019 Dec 3;140(23):1917-1920. doi: 10.1161/CIRCULATIONAHA.119.043773. Epub 2019 Sep 25. Circulation. 2019. PMID: 31553225 No abstract available.
Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis.
Iwamoto N, Sato S, Kurushima S, Michitsuji T, Nishihata S, Okamoto M, Tsuji Y, Endo Y, Shimizu T, Sumiyoshi R, Suzuki T, Okada A, Koga T, Kawashiri SY, Fujikawa K, Igawa T, Aramaki T, Ichinose K, Tamai M, Nakamura H, Mizokami A, Origuchi T, Ueki Y, Eguchi K, Kawakami A. Iwamoto N, et al. Among authors: ueki y. Arthritis Res Ther. 2021 Jul 23;23(1):197. doi: 10.1186/s13075-021-02582-z. Arthritis Res Ther. 2021. PMID: 34301311 Free PMC article.
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C, Koskinas KC, Ueki Y, Losdat S, Häner JD, Bär S, Otsuka T, Inderkum A, Jensen MRJ, Lonborg J, Fahrni G, Ondracek AS, Daemen J, van Geuns RJ, Iglesias JF, Matter CM, Spirk D, Juni P, Mach F, Heg D, Engstrom T, Lang I, Windecker S, Räber L. Zanchin C, et al. Among authors: ueki y. Am Heart J. 2021 Aug;238:33-44. doi: 10.1016/j.ahj.2021.04.006. Epub 2021 May 2. Am Heart J. 2021. PMID: 33951415 Clinical Trial.
Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation.
Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, Kawakami A, Takei S, Tonomura K, Inoue M, Kobayashi H, Okafuji I, Sakurai Y, Kato N, Maruyama Y, Inoue Y, Otsubo Y, Makino T, Okada S, Kobayashi I, Yashiro M, Ito S, Fujii H, Kondo Y, Okamoto N, Ito S, Iwata N, Kaneko U, Doi M, Hosokawa J, Ohara O, Saito MK, Nishikomori R; PIDJ members in the JSIAD; PIDJ (Primary Immunodeficiency and Autoinflammatory Diseases Database Project) members in the JSIAD (Japanese Society for Immunodeficiency and Autoinflammatory Diseases). Matsuda T, et al. Among authors: ueki y. Ann Rheum Dis. 2020 Nov;79(11):1492-1499. doi: 10.1136/annrheumdis-2020-217320. Epub 2020 Jul 9. Ann Rheum Dis. 2020. PMID: 32647028
Characteristics of  SARS-CoV-2 super-spreaders in Japan.
Kawahara T, Ueki Y, Nawa N, Miyamae S, Hanafusa M, Goto Y, Tohda S, Fujiwara T. Kawahara T, et al. Among authors: ueki y. J Infect. 2022 Feb;84(2):e6-e9. doi: 10.1016/j.jinf.2021.12.036. Epub 2021 Dec 30. J Infect. 2022. PMID: 34974057 Free PMC article. No abstract available.
614 results